Insider filing · VCYT
Rebecca Chambers
Chief Financial Officer
profile →
Veracyte, Inc.
VCYT · Healthcare · 50 filings in 24 months
ticker →
Rebecca Chambers sold $287K of Veracyte (VCYT)
Executed Nov 5 2025, disclosed Nov 7 2025, 2 days later.
Value, as filed
$287K
7,000 sh × $41.00
Executed
Nov 5 2025
the trade date, as filed
Disclosed
Nov 7 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RCRebecca Chambers (Chief Financial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $663K of VCYT (18,341 sh across 2 lots, as filed), executed Mar 4.
The name
VCYTHealthcare · Veracyte, Inc. operates as a diagnostics company in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Rebecca Chambers in VCYT
VCYTSALE
Veracyte, Inc.
$106K2,477 sh × $42.81
Exec Sep 4
Filed Sep 4 · 7:54 PM ET VCYTSALE Veracyte, Inc. $663K
18,341 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET VCYTSALE Veracyte, Inc. $622K
13,278 sh across 2 lots
Exec Dec 4 2025
Filed Dec 4 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $303K
7,000 sh × $43.23
Exec Dec 3 2024
Filed Dec 4 2024 · 5:30 PM ET VCYTSALE Veracyte, Inc. $586K
15,275 sh × $38.34
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET